| (210) | Number of the EPO application | 18815386 |
| (220) | Filing date of the EPO application | 2018.11.01 |
| (80) | EPO patent specification publication (B) | EPB nr. 49/2024, 2024.12.04 |
| (110) | EPO patent number | 3703750 |
| (21) | Number of the application | e 2020 0917 |
| (71) | Name(s) of applicant(s), code of the country | Juno Therapeutics, Inc., US;
MEMORIAL SLOAN KETTERING CANCER CENTER, US; |
| (72) | Name(s) of inventor(s), code of the country | SATHER Blythe D., US;
SMITH Eric L., US;
AMIN Rupesh, US;
CHEN Aye, US;
HARRINGTON Kimberly, US;
HAUSKINS Collin, US;
HESS Erik, US;
DE IMUS Cyr, US;
JONES Jon, US;
OLSHEFSKY Audrey, US;
PONKO Stefan, US;
SALMON Ruth, US;
TAREEN Semih, US;
WU Rebecca, US;
CHEN Yan, US;
STIRNER Mariana Cota, US;
SHAMAH Steven M., US;
DUTTA-SIMMONS Jui, US;
WORKS Melissa, US;
PAZMANY Csaba, US; |
| (73) | Name(s) of owner(s), code of the country | JUNO Therapeutics Inc., US;
MEMORIAL SLOAN KETTERING CANCER CENTER, US; |
| (54) | Title of the invention | CHIMERIC ANTIGEN RECEPTORS SPECIFIC FOR B-CELL MATURATION ANTIGEN AND ENCODING POLYNUCLEOTIDES |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | A61K 39/395 (2006.01.01); C07K 16/28 (2006.01.01); A61P 39/02 (2006.01.01); A61P 35/00 (2006.01.01); C07K 14/725 (2006.01.01); A61K 35/17 (2015.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2020.09.30 |
| (30) | Priority | 201762580439 P, 2017.11.01, US; 201762580445 P, 2017.11.01, US; 201762582932 P, 2017.11.07, US; 201762582938 P, 2017.11.07, US; 201762596763 P, 2017.12.08, US; 201762596765 P, 2017.12.08, US; 201862614960 P, 2018.01.08, US; 201862614963 P, 2018.01.08, US; 201862665442 P, 2018.05.01, US; 201862665447 P, 2018.05.01, US |
| (86) | International application | PCT/US2018/058811, 2018.11.01 |
| (87) | International publication | WO 2019/090003, 2019.05.09 |